Fortrea Holdings (FTRE) Depreciation & Amortization (CF) (2022 - 2026)

Fortrea Holdings (FTRE) reported Depreciation & Amortization (CF) of $19.8 million for Q1 2026, up 1.54% on a YoY basis from $19.5 million in Q1 2025, and up 2.59% quarter-over-quarter from $19.3 million in Q4 2025.

Fortrea Holdings (FTRE) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Depreciation & Amortization (CF) for 5 years, with the latest figure at $19.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 1.54% year-over-year to $19.8 million; the trailing twelve-month figure through Mar 2026 stood at $78.3 million (down 5.55% YoY), and the FY2025 full-year result was $78.0 million, down 10.24% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $19.8 million, up from $19.3 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $25.1 million in Q2 2023, with the low at $19.3 million in Q4 2025.
  • Historically, Depreciation & Amortization (CF) has averaged $22.0 million across 5 years, with a median of $22.0 million in 2022.
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) grew 8.37% — and 2025, when it declined 17.02%.
  • Fortrea Holdings' Depreciation & Amortization (CF) stood at $23.9 million in 2022, then increased by 2.09% to $24.4 million in 2023, then slipped by 14.75% to $20.8 million in 2024, then slipped by 7.21% to $19.3 million in 2025, then increased by 2.59% to $19.8 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $19.8 million (Q1 2026), $19.3 million (Q4 2025), and $19.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 429,663.65
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 19.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.80 Mn
Mar 31, 2026 19.80 Mn
Dec 31, 2025 19.30 Mn
Dec 31, 2025 19.30 Mn
Sep 30, 2025 19.60 Mn
Sep 30, 2025 19.60 Mn
Jun 30, 2025 19.60 Mn
Jun 30, 2025 19.60 Mn
Mar 31, 2025 19.50 Mn
Mar 31, 2025 19.50 Mn
Dec 31, 2024 20.80 Mn
Dec 31, 2024 20.80 Mn
Sep 30, 2024 21.20 Mn
Sep 30, 2024 21.20 Mn
Jun 30, 2024 21.40 Mn
Jun 30, 2024 21.40 Mn
Mar 31, 2024 23.50 Mn
Mar 31, 2024 23.50 Mn
Dec 31, 2023 24.40 Mn
Dec 31, 2023 24.40 Mn